Galaxy Surfactants Q1FY27 EBITDA Surges 86.9% YoY to ₹252.5 Crore
Galaxy Surfactants reported a record quarterly EBITDA of ₹252.5 crore for Q1FY27, an 86.9% YoY increase. Total revenue grew 38.5% YoY to ₹1,785.2 crore, and PAT rose 108.7% YoY to ₹165.9 crore. Consolidated volumes saw mid-single digit growth.
The announcement details record financial results, including substantial increases in EBITDA, revenue, and profit, which are material for investors and the company's market position.
The company reported its highest-ever quarterly EBITDA, significant year-on-year growth in revenue and profit, and healthy volume growth, indicating a strong financial performance.
Galaxy Surfactants Limited has announced its financial results for the quarter ended June 30, 2026, reporting its highest-ever quarterly EBITDA of ₹252.5 crore, a significant increase from ₹135.1 crore in Q1FY26. The company also saw its EBITDA per metric ton (MT) improve to approximately ₹35,458/MT from ₹20,009/MT year-on-year.
Consolidated volumes grew by mid-single digits year-on-year, with the India region returning to double-digit volume growth. The Specialty Care business maintained its momentum across international markets. While the AMET region experienced a low-single digit decline in volumes due to geopolitical developments in West Asia, it witnessed a strong sequential recovery during the quarter.
Total revenue for the quarter stood at ₹1,785.2 crore, an increase of 38.5% year-on-year. Profit After Tax (PAT) was ₹165.9 crore, up 108.7% year-on-year. The company attributed its strong performance to operational excellence, a diversified product portfolio, an agile supply chain, strong vendor relationships, and disciplined pricing actions, enabling it to navigate feedstock price fluctuations and supply-chain disruptions.
Commenting on the performance, Mr. K. Natarajan, Managing Director, stated, "Our ability to anticipate risks, manage volatility, make disciplined commercial decisions and leverage a diversified portfolio has enabled us to emerge stronger despite a challenging external environment." He expressed confidence in the company's ability to deliver sustainable long-term growth.
What to do with a filing like this
Galaxy Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Galaxy Surfactants Limited. Read the original for the full detail.